Cargando…

HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress

BACKGROUND: The key role of hypoxia‐inducible factor 2alpha (HIF2α) in the process of renal cancer has been confirmed. In the field of tumour research, oxidative stress is also considered to be an important influencing factor. However, the relationship and biological benefits of oxidative stress and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jian, Xiong, Zhiyong, Wang, Keshan, Yuan, Changfei, Huang, Yu, Xiao, Wen, Meng, Xiangui, Chen, Zhixian, Lv, Qingyang, Miao, Daojia, Liang, Huageng, Xu, Tianbo, Xie, Kairu, Yang, Hongmei, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567048/ https://www.ncbi.nlm.nih.gov/pubmed/34841698 http://dx.doi.org/10.1002/ctm2.592

Ejemplares similares

As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner
por: Miao, Daojia, et al.
Publicado: (2022)

The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling
por: Shi, Jian, et al.
Publicado: (2023)

Impact of inflammation and immunotherapy in renal cell carcinoma
por: Shi, Jian, et al.
Publicado: (2020)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma
por: Tan, Diaoyi, et al.
Publicado: (2023)

Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression
por: Meng, Xiangui, et al.
Publicado: (2020)

NNT‐induced tumor cell “slimming” reverses the pro‐carcinogenesis effect of HIF2a in tumors
por: Xiong, Zhiyong, et al.
Publicado: (2021)

Downregulation of miR-29c promotes muscle wasting by modulating the activity of leukemia inhibitory factor in lung cancer cachexia
por: Xie, Kairu, et al.
Publicado: (2021)

N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway
por: Miao, Daojia, et al.
Publicado: (2023)

Overexpression of PPT2 Represses the Clear Cell Renal Cell Carcinoma Progression by Reducing Epithelial-to-mesenchymal Transition
por: Yuan, ChangFei, et al.
Publicado: (2020)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2019)

Tumor Cell “Slimming” Regulates Tumor Progression through PLCL1/UCP1‐Mediated Lipid Browning
por: Xiong, Zhiyong, et al.
Publicado: (2022)

Folic acid-modified Exosome-PH20 enhances the efficiency of therapy via modulation of the tumor microenvironment and directly inhibits tumor cell metastasis
por: Feng, Chunxiang, et al.
Publicado: (2020)

The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2017)

NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Lin, Yongshuai, et al.
Publicado: (2022)

HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
por: Hoefflin, Rouven, et al.
Publicado: (2020)

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma
por: Li, Weiquan, et al.
Publicado: (2022)

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis
por: Wang, Qi, et al.
Publicado: (2023)

Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia
por: Hu, Wenjun, et al.
Publicado: (2021)

LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma
por: Wang, KeShan, et al.
Publicado: (2019)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

LINC00160 mediates sunitinib resistance in renal cell carcinoma via SAA1 that is implicated in STAT3 activation and compound transportation
por: Cheng, Gong, et al.
Publicado: (2020)

Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress
por: Xiong, Zhiyong, et al.
Publicado: (2020)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)

Role of the NUDT Enzymes in Breast Cancer
por: Wright, Roni H. G., et al.
Publicado: (2021)

TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress
por: Yuan, Hongwei, et al.
Publicado: (2023)

Nudt3 is an mRNA decapping enzyme that modulates cell migration
por: Grudzien-Nogalska, Ewa, et al.
Publicado: (2016)

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
por: Wang, Keshan, et al.
Publicado: (2018)

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Importance of NUDT15 Polymorphisms in Thiopurine Treatments
por: Tanaka, Yoichi, et al.
Publicado: (2021)

A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma
por: Cheng, Gong, et al.
Publicado: (2019)

Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
por: Page, Brent D. G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dbej20etv3ptm18ho697u10b84